Omada Health shares jumped after the company made its public-market debut, propelled by Americans’ renewed focus on how ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...

The percentage of adult patients with a diagnosis of overweight or obesity increased from 10.4% in 2019 to 15.7% in 2024.

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...